Treatment of neurolept-induced tardive dyskinesia

被引:39
作者
Jankelowitz, Stacey K. [1 ]
机构
[1] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia
来源
NEUROPSYCHIATRIC DISEASE AND TREATMENT | 2013年 / 9卷
关键词
tardive dyskinesia; treatment; neuroleptic agents; PLACEBO-CONTROLLED TRIAL; DEEP BRAIN-STIMULATION; SCHIZOPHRENIA SPECTRUM DISORDERS; HYPERKINETIC MOVEMENT-DISORDERS; GENETIC ASSOCIATION ANALYSIS; VITAMIN-E TREATMENT; OPEN-LABEL TRIAL; 1A2; CYP1A2; GENE; DOUBLE-BLIND; RECEPTOR GENE;
D O I
10.2147/NDT.S30767
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tardive dyskinesia (TDK) includes orobuccolingual movements and "piano-playing" movements of the limbs. It is a movement disorder of delayed onset that can occur in the setting of neuroleptic treatment as well as in other diseases and following treatment with other drugs. The specific pathophysiology resulting in TDK is still not completely understood but possible mechanisms include postsynaptic dopamine receptor hypersensitivity, abnormalities of striatal gamma-aminobutyric acid (GABA) neurons, and degeneration of striatal cholinergic interneurons. More recently, the theory of synaptic plasticity has been proposed. Considering these proposed mechanisms of disease, therapeutic interventions have attempted to manipulate dopamine, GABA, acetylcholine, norepinephrine and serotonin pathways and receptors. The data for the effectiveness of each class of drugs and the side effects were considered in turn.
引用
收藏
页码:1371 / 1380
页数:10
相关论文
共 50 条
  • [21] Tardive dyskinesia update: treatment and management
    Owens, David Cunningham
    BJPSYCH ADVANCES, 2019, 25 (02) : 78 - 89
  • [22] Treatment of tardive dyskinesia: A systematic review (1997-2011)
    Alimi, M.
    Gaillard, P.
    Camus, V.
    El-Hage, W.
    EUROPEAN JOURNAL OF PSYCHIATRY, 2013, 27 (03) : 160 - 173
  • [23] Oxidative stress and tardive dyskinesia: Pharmacogenetic evidence
    Cho, Chul-Hyun
    Lee, Heon-Jeong
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 46 : 207 - 213
  • [24] Melatonin for the treatment of tardive dyskinesia
    Nelson, LA
    McGuire, JM
    Hausafus, SN
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (7-8) : 1128 - 1131
  • [25] Tardive Dyskinesia
    Aia, Pratibha G.
    Revuelta, Gonzalo J.
    Cloud, Leslie J.
    Factor, Stewart A.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2011, 13 (03) : 231 - 241
  • [26] Tetrabenazine for the Treatment of Tardive Dyskinesia
    Leung, Jonathan G.
    Breden, Ericka L.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) : 525 - 531
  • [27] Deep Brain Stimulation in the Treatment of Tardive Dyskinesia
    Szczakowska, Adrianna
    Gabryelska, Agata
    Gawlik-Kotelnicka, Oliwia
    Strzelecki, Dominik
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [28] Treatment Strategies for Tardive Dyskinesia
    Kremens, Daniel E.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (01)
  • [29] A new era in the diagnosis and treatment of tardive dyskinesia
    Caroff, Stanley N.
    Cutler, Andrew J.
    CNS SPECTRUMS, 2023, 28 (04) : 401 - 415
  • [30] Tardive Dyskinesia: Treatment Update
    Divya Arya
    Tarannum Khan
    Adam J. Margolius
    Hubert H. Fernandez
    Current Neurology and Neuroscience Reports, 2019, 19